Pfizer asks US to authorize Covid pill: statement

WASHINGTON: US pharmaceutical company Pfizer on Tuesday asked regulators to grant its Covid pill emergency use authorization after the medicine was shown to cut hospitalization or death by nearly 90 percent among newly-infected high risk patients.

“With more than five million deaths and countless lives impacted by this devastating disease globally, there is an urgent need for life-saving treatment options,” Pfizer CEO Albert Bourla said in a statement.